Kangpei Biotech Announces Board Resolution on Issuance of Restricted Stock Units for 2025 Fiscal Year
AI Summary (NQ-processed)
Kangpei Biotech Co., Ltd. has resolved to issue 23,000 new restricted stock units for its employees for the 2025 fiscal year, with the capital increase base date set as June 26, 2026.
AI Analysis
Frequently Asked Questions
Q: How does Kangpei's stock issuance affect shareholders?
A: It may dilute ownership, but aims to secure talent for long-term growth.
Q: What are restricted stock units?
A: Shares granted to employees with vesting conditions based on tenure or performance.
Q: Where is Kangpei Biotech based?
A: The company is headquartered in Taipei, Taiwan, focusing on biopharmaceutical innovation.